Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 551.00p on 30-03-2026 at 19:16:25
Change -10.00p -1.78%
Buy 549.00p
Sell 546.00p
Last Trade: Buy 115.00 at 551.00p
Day's Volume: 334,204
Last Close: 551.00p
Open: 548.00p
ISIN: GB00BDFBVT43
Day's Range 542.00p - 566.00p
52wk Range: 232.50p - 950.00p
Market Capitalisation: £666.01m
VWAP: 552.37423p
Shares in Issue: 120.87m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 115 551.00p SI Trade
Negotiated Trade
16:50:08 - 30-Mar-26
Buy* 2,771 552.78p SI Trade
Negotiated Trade
16:47:09 - 30-Mar-26
Buy* 481 551.00p Automatic Execution
16:36:31 - 30-Mar-26
Sell* 543 551.00p Automatic Execution
16:36:12 - 30-Mar-26
Sell* 1,479 551.00p Automatic Execution
16:36:12 - 30-Mar-26
Sell* 754 551.00p Automatic Execution
16:36:12 - 30-Mar-26
Sell* 667 551.00p Automatic Execution
16:36:12 - 30-Mar-26
Sell* 102,026 551.00p Uncrossing Trade
16:35:27 - 30-Mar-26
Sell* 396 547.00p Automatic Execution
16:29:50 - 30-Mar-26
Sell* 23 548.00p Automatic Execution
16:29:34 - 30-Mar-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Mar 2026 (Fri) 568.00 570.00 559.00 561.00 329,929
26th Mar 2026 (Thu) 606.00 615.00 555.00 575.00 759,214
25th Mar 2026 (Wed) 580.00 608.00 580.00 606.00 402,105
24th Mar 2026 (Tue) 600.00 604.00 589.00 593.00 196,377
23rd Mar 2026 (Mon) 593.00 626.00 583.00 602.00 346,592
20th Mar 2026 (Fri) 613.00 626.00 601.00 617.00 654,479
19th Mar 2026 (Thu) 630.00 638.00 618.00 618.00 246,841
18th Mar 2026 (Wed) 630.00 661.00 630.00 644.00 538,383
17th Mar 2026 (Tue) 650.00 650.00 625.00 637.00 243,628
16th Mar 2026 (Mon) 642.00 642.00 625.00 633.00 93,494
13th Mar 2026 (Fri) 630.00 638.00 622.00 630.00 104,796
12th Mar 2026 (Thu) 630.00 641.00 625.00 631.00 164,565
11th Mar 2026 (Wed) 672.00 672.00 630.00 637.00 138,514
10th Mar 2026 (Tue) 591.00 651.00 591.00 651.00 202,230
9th Mar 2026 (Mon) 610.00 615.00 592.00 615.00 259,659
6th Mar 2026 (Fri) 669.00 669.00 614.00 624.00 206,795
5th Mar 2026 (Thu) 656.00 659.00 637.00 638.00 127,926
4th Mar 2026 (Wed) 635.00 659.00 617.00 659.00 285,432
3rd Mar 2026 (Tue) 670.00 670.00 616.00 626.00 373,910
2nd Mar 2026 (Mon) 662.00 662.00 630.00 645.00 329,716
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
26th Mar 2026 7:00 am RNS Preliminary results for the year ended 31 Dec 2025
18th Mar 2026 7:00 am RNS-R Licensing agreement with VVMF
9th Mar 2026 7:53 am RNS Admission to Trading
4th Mar 2026 11:45 am RNS Admission to Trading Application
3rd Mar 2026 7:00 am RNS Capital Markets Day and investor conferences
2nd Mar 2026 7:00 am RNS Total Voting Rights
27th Feb 2026 1:31 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 3:20 pm RNS Form 8.3 - Oxford Biomedica plc
26th Feb 2026 1:49 pm RNS Form 8.5 (EPT/RI)-Replacement of Oxford Biomedica
26th Feb 2026 12:33 pm RNS Form 8.3 - Oxford Biomedica plc
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

WINNERS & LOSERS: Miners climb; Close Brothers down before FCA verdict

30th Mar 2026 09:47

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More

Oxford BioMedica shares fall as warns on loss-making first half

26th Mar 2026 12:07

(Alliance News) - Oxford BioMedica PLC on Thursday warned the first half of 2026 will be loss-making as the year will be skewed to the second half. Read More

LONDON BROKER RATINGS: Goldman raises Croda; Jefferies likes Diploma

23rd Mar 2026 09:01

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

UK earnings, trading statements calendar - next 7 days

19th Mar 2026 14:38

Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,127.96
Change160.61

Login to your account

Forgot Password?

Not Registered